Combination therapy for the treatment of prostate cancer

• 收藏
• 分享

专利权人:

Oncbiomune LLC

发明人:

HEAD, Jonathan,ELLIOTT, Robert

申请号：

ES12701292

公开号：

ES2637637T3

申请日:

2012.01.09

申请国别(地区):

ES

年份:

2017

代理人:

摘要：

A composition comprising approximately 50 µg of prostate specific antigen (PSA), approximately 2 µg of CEA, approximately 1000 IU of CA 125, approximately 20,000 units of IL-2 and approximately 16.7 µg of GM-CSF, per 100 µl of the composition.Una composición que comprende aproximadamente 50 μg de antígeno prostático específico (PSA), aproximadamente 2 μg de CEA, aproximadamente 1000 UI de CA 125, aproximadamente 20.000 unidades de IL-2 y aproximadamente 16,7 μg de GM-CSF, por 100 μl de la composición.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/